Article
Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells.
Atherosclerosis. Supplements - 1 May 2015
Opgenoorth Mirian, Wagner Andrea, Passauer Jens, Hohenstein Bernd, Hugo Christian
Abstract excerpt
OBJECTIVE: Antibody-mediated rejection (AMR) is associated with poor allograft survival. Therefore, effective treatment strategies are required. Extracorporeal strategies are increasingly included in treatment of antibody-mediated rejection to eliminate the detrimental alloantibodies. Yet, other mechanisms contributing to the beneficial effect of apheresis besides the removal of antibodies are under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
